Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study

Affiliations

• ¹ School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
• ² Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
• ³ Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
• ⁴ Division of Endocrinology, Jewish General Hospital, Montreal, Quebec, Canada.
• ⁵ Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
• ⁶ Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
• ⁷ Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
• ⁸ Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
• ⁹ School of Pharmacy, Sungkyunkwan University, Suwon, South Korea shin.jy@skku.edu.